MARAVAI LIFESCIENCES HOLDINGS INC. - CLASS A COMM

Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation

19 Oct 2022 07:10:00 By Nasdaq GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022

18 Oct 2022 15:15:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces CEO Leadership Transition

03 Oct 2022 15:05:00 By Nasdaq GlobeNewswire

TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product

13 Sep 2022 07:00:02 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces September 2022 Investor Conference Schedule

15 Aug 2022 15:05:00 By Nasdaq GlobeNewswire

CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results

04 Aug 2022 15:51:37 By Nasdaq GlobeNewswire

Maravai Lifesciences Reports Second Quarter 2022 Financial Results

04 Aug 2022 15:03:00 By Nasdaq GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 4, 2022

19 Jul 2022 07:00:01 By Nasdaq GlobeNewswire

TriLink BioTechnologies, part of Maravai LifeSciences, Expands R&D Leadership Team

06 Jul 2022 15:05:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Strengthens Executive Leadership Team to Support Long-Term Growth

27 Jun 2022 07:00:01 By Nasdaq GlobeNewswire

TriLink BioTechnologies, Part of Maravai LifeSciences, Announces Cooperative Agreement With Department of Defense

24 May 2022 07:00:01 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule

11 May 2022 15:05:01 By Nasdaq GlobeNewswire

Maravai LifeSciences Reports First Quarter 2022 Financial Results

05 May 2022 15:05:02 By Nasdaq GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022

21 Apr 2022 16:01:50 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces March 2022 Investor Conference Schedule

09 Mar 2022 15:30:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance

23 Feb 2022 15:05:01 By Nasdaq GlobeNewswire

Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides

28 Jan 2022 07:00:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces Upcoming Investor Events

25 Jan 2022 16:05:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces Debt Repricing

20 Jan 2022 15:05:00 By Nasdaq GlobeNewswire

Maravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022

05 Jan 2022 07:00:02 By Nasdaq GlobeNewswire